You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hyperkalaemia

Showing 1 - 25 of 2,501
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hyperkalaemia and Its Impact on Therapy With RAASi

Recruiting
  • Hyperkalaemia
  • +2 more
    • Portsmouth, United Kingdom
      Portsmouth Hospitals University NHS Trust
    Nov 10, 2022

    Hyperkalemia Trial in Miami (Patiromer)

    Not yet recruiting
    • Hyperkalemia
    • Miami, Florida
      Investigator Site 84003
    Mar 10, 2023

    A Multicenter, Prospective, Non-interventional Cohort Study to

    Recruiting
    • Hyperkalaemia
      • Dalian, China
        The First Affiliated Hospital of Dalian Medical University
      Jun 14, 2022

      Recurrence and Treatment in Haemodialysis

      Completed
      • Hyperkalemia
      • +2 more
      • observational study
      • Beijing, Beijing, China
      • +11 more
      Aug 12, 2022

      Hyperkalaemia Trial in West Palm Beach (Sodium Zirconium Cyclosilicate (SZC), Enhanced dietary advice, Standard dietary advice

      Terminated
      • Hyperkalaemia
      • Sodium Zirconium Cyclosilicate (SZC)
      • +2 more
      • West Palm Beach, Florida
        Research Site
      Feb 21, 2022

      Patient Palatability and Preference of 3 Potassium Binders in

      Completed
      • Chronic Kidney Disease + Hyperkalaemia +/- Heart Failure
      • Calcium Polystyrene Sulphonate 15g/60 mL water
      • +4 more
      • Temple Terrace, Florida
      • +17 more
      Dec 13, 2022

      Oral Resin for Treatment of Hyperkalemia in Chinese Renal

      Not yet recruiting
      • Hyperkalaemia
        • (no location specified)
        Jul 14, 2022

        Chronic Kidney Diseases, Heart Failure With Reduced Ejection Fraction, Hyperkalemia Trial in London (Lokelma Oral Product)

        Recruiting
        • Chronic Kidney Diseases
        • +4 more
        • Lokelma Oral Product
        • London, United Kingdom
          St Georges, University of London
        Feb 16, 2022

        Hyperkalaemia Trial in Berlin (Tacrolimus, Cyclosporin, Sodium Zirconium Cyclosilicate)

        Completed
        • Hyperkalaemia
        • Berlin, Germany
          Research Site
        May 9, 2022

        Heart Failure With Reduced Ejection Fraction, Hyperkalemia Trial in A Coruña

        Completed
        • Heart Failure With Reduced Ejection Fraction
        • Hyperkalemia
          • A Coruña, Spain
            Complejo Hospitalario Universitario de A Coruña (CHUAC)
          May 20, 2021

          Hyperkalaemia, Chronic Kidney Disease Trial in Worldwide (Sodium Zirconium Cyclosilicate (SZC), Local standard of care)

          Recruiting
          • Hyperkalaemia
          • Chronic Kidney Disease
          • Sodium Zirconium Cyclosilicate (SZC)
          • Local standard of care
          • Belgium, Belgium
          • +37 more
          Aug 8, 2022

          Hyperkalemia Trial in China (Sodium Zirconium Cyclosilicate, Placebo)

          Completed
          • Hyperkalemia
          • Sodium Zirconium Cyclosilicate
          • Placebo
          • Baotou, China
          • +35 more
          Feb 21, 2022

          Heart Failure, Hyperkalemia Trial in Worldwide

          Recruiting
          • Heart Failure
          • Hyperkalemia
            • Little Rock, Arkansas
            • +84 more
            Jun 2, 2022

            IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin

            Not yet recruiting
            • Hyperkalemia
            • No intervention
            • (no location specified)
            Aug 10, 2020

            Renal Insufficiency, Chronic, Hyperkalemia Trial in Worldwide (Sodium Zirconium Cyclosilicate (SZC), Placebo, Lisinopril)

            Recruiting
            • Renal Insufficiency, Chronic
            • Hyperkalemia
            • Sodium Zirconium Cyclosilicate (SZC)
            • +4 more
            • Tucson, Arizona
            • +281 more
            Jan 10, 2023

            Hyperkalemia, Renal Insufficiency, Chronic Trial in China (Patiromer Powder for Oral Suspension (Part A), Placebo (Part B),

            Recruiting
            • Hyperkalemia
            • Renal Insufficiency, Chronic
            • Patiromer Powder for Oral Suspension (Part A)
            • +2 more
            • Hefei, Anhui, China
            • +21 more
            Sep 15, 2022

            Hyperkalaemia, Heart Failure With Reduced Ejection Fraction Trial in Worldwide (Sodium zirconium cyclosilicate, Placebo,

            Recruiting
            • Hyperkalaemia
            • Heart Failure With Reduced Ejection Fraction
            • Sodium zirconium cyclosilicate
            • +2 more
            • Fairhope, Alabama
            • +126 more
            Jan 20, 2023

            Hyperkalaemia, Metabolic Acidosis, Chronic Kidney Disease Trial in Puerto Rico, United States (Sodium zirconium cyclosilicate,

            Terminated
            • Hyperkalaemia
            • +2 more
            • Sodium zirconium cyclosilicate
            • Placebo
            • Florence, Alabama
            • +29 more
            Dec 7, 2022

            Heart Failure,Congestive Trial in United Kingdom (Patiromer)

            Suspended
            • Heart Failure，Congestive
            • Glasgow, Strathclyde, United Kingdom
            • +10 more
            Mar 18, 2022

            Chronic Kidney Disease, Type 1 Diabetes Trial in Worldwide (Finerenone, Placebo)

            Not yet recruiting
            • Chronic Kidney Disease
            • Type 1 Diabetes Mellitus
            • Stanford, California
            • +46 more
            Jun 15, 2023

            Hyperkalemia, Potassium Imbalance, Electrolyte Imbalance Trial in Seeb (Insulin regular, Dextrose 50, salbutamol)

            Not yet recruiting
            • Hyperkalemia
            • +3 more
            • Insulin regular
            • +2 more
            • Seeb, Muscat, Oman
              Sultan Qaboos University hospital
            Sep 11, 2023

            Heart Failure With Moderately Reduced Ejection Fraction Trial (Sacubitril / Valsartan, Ramipril)

            Not yet recruiting
            • Heart Failure With Moderately Reduced Ejection Fraction
            • (no location specified)
            Aug 18, 2022

            CKD, Diabetes, Type 2, Hyperkalemia Trial in London (Sodium Zirconium Cyclosilicate, Placebo)

            Not yet recruiting
            • CKD
            • +2 more
            • Sodium Zirconium Cyclosilicate
            • Placebo
            • London, Uk, United Kingdom
              Kieran Mccafferty
            Mar 17, 2022

            Heart Failure With Reduced Ejection Fraction Trial in Porto (Sacubitril-valsartan, SGLT2 inhibitor)

            Recruiting
            • Heart Failure With Reduced Ejection Fraction
            • Porto, Portugal
            • +3 more
            Aug 9, 2023

            Diabetes Type 2 With Proteinuria, Diabetes, Type 2, Diabetes Trial (drug, device, diagnostic test, behavioral)

            Not yet recruiting
            • Diabetes Mellitus Type 2 With Proteinuria
            • +12 more
            • Empagliflozin 10 MG
            • +6 more
            • (no location specified)
            Oct 17, 2023